INBX · Inhibrx Biosciences, Inc.
$84.09
-3.30 (-3.78%)
At close · Jul 20
Market Cap
$1.23B
Shares
14.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-07-16 | 2026-07-15 | |
| 8-K | 2026-06-15 | — | |
| 8-K | 2026-06-03 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| 8-K | 2026-05-14 | — | |
| 8-K | 2026-05-11 | — | |
| DEF 14A | 2026-04-23 | 2025-12-31 | |
| 8-K | 2026-04-21 | — | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-19 | — | |
| 8-K | 2026-02-23 | — | |
| 8-K | 2025-12-16 | — | |
| 8-K | 2025-11-14 | — | |
| 10-Q | 2025-11-14 | 2025-09-30 | |
| 8-K | 2025-10-23 | — | |
| 10-Q | 2025-08-13 | 2025-06-30 | |
| 8-K | 2025-08-13 | — | |
| 8-K | 2025-05-28 | — | |
| 10-Q | 2025-05-14 | 2025-03-31 | |
| 8-K | 2025-05-14 | — | |
| DEF 14A | 2025-04-16 | 2024-12-31 | |
| 8-K | 2025-04-01 | 2025-03-31 | |
| 8-K | 2025-03-17 | — | |
| 10-K | 2025-03-17 | 2024-12-31 | |
| 8-K | 2025-01-21 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-11-14 | — | |
| 10-Q | 2024-11-14 | 2024-09-30 | |
| 8-K | 2024-11-04 | — | |
| 8-K | 2024-08-13 | — | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-05-30 | 2024-05-29 | |
| 8-K | 2024-05-24 | — |
Showing 1–34 of 34 filings